BAMCO Inc
FLXN

BAMCO Inc’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BAMCO Inc’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-675,000
Closed -$8.42M – 379
2019
Q1 		$8.42M Buy
675,000
+290,000
+75% +$3.88M 0.04% 216
2018
Q4 		$4.36M Hold
385,000
– – 0.02% 246
2018
Q3 		$7.2M Buy
385,000
+158,700
+70% +$3.65M 0.03% 224
2018
Q2 		$5.85M Buy
226,300
+50,000
+28% +$1.3M 0.03% 225
2018
Q1 		$3.95M Sell
176,300
-50,000
-22% -$1.22M 0.02% 245
2017
Q4 		$5.67M Buy
226,300
+16,800
+8% +$411K 0.03% 231
2017
Q3 		$5.07M Hold
209,500
– – 0.02% 225
2017
Q2 		$4.24M Buy
209,500
+104,100
+99% +$2.17M 0.02% 235
2017
Q1 		$2.84M Buy
105,400
+31,400
+42% +$641K 0.02% 241
2016
Q4 		$1.41M Buy
74,000
+36,000
+95% +$688K 0.01% 265
2016
Q3 		$743K Buy
38,000
+11,000
+41% +$186K ﹤0.01% 284
2016
Q2 		$404K Buy
+27,000
New +$339K ﹤0.01% 283

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return